Company: SCLXW
Filing Date: 2025-10-28
Form Type: PRE 14A
Source: 0001193125-25-253884
Chunk: 21

Company: Scilex Holding Co
Filing Date: 2025-10-28
Form: PRE 14A
Chunk 21
---
5.13 | % |     |             |   9,999 |     | $        | 282.80 |     |                |  3.46 | % |
| Jay Chun, M.D., Ph.D., Director                                          |     |                |  29,857 |     | $              | 17.50-$49.35  |     |             |  1.98 | % |     |             |       — |     |          |      — |     |                |     — |   |
| Dorman Followwill, Director                                              |     |                |  30,384 |     | $              | 17.50-$282.80 |     |             |  2.01 | % |     |             |   4,698 |     | $        | 282.80 |     |                |  1.62 | % |
| Yue Alexander Wu, Ph.D., Director                                        |     |                |  41,402 |     | $              | 17.50-$60.55  |     |             |  2.74 | % |     |             |       — |     |          |      — |     |                |     — |   |

| (1) | Represents the aggregate number of options outstanding and held by the individual under all of the 
 Company’s existing equity incentive plans (including the 2022 Plan).                               |

| (2) | Determined by dividing the number of stock options held by the individual by 1,511,113, which is the total                                            
 number of outstanding stock options under all of the Company’s existing incentive equity plans (including the 2022 Plan) as of the date of the table. |

13

| (3) | Determined by dividing the number of stock options held by the individual that are eligible for the Option   
 Repricing by 289,405, which is the total number of outstanding Eligible Options as of the date of the table. |

Vote Required The approval of the Option Repricing Proposal requires the affirmative vote of the holders of a majority of the votes cast affirmatively or negatively (excluding abstentions) at the Special Meeting by the holders entitled to vote thereon. Stockholder abstentions will not have any effect on the outcome of this proposal, so long as a quorum exists. Broker non-voteswill have no effect on the outcome of this proposal. THE BOARD OF DIRECTORS RECOMMENDS A VOTE “